93 related articles for article (PubMed ID: 29321183)
1.
Freitas-Alves DR; Vieira-Monteiro HA; Piranda DN; Sobral-Leite M; da Silva TSL; Bergmann A; Valença SS; Perini JA; Vianna-Jorge R
Endocr Relat Cancer; 2018 Mar; 25(3):351-365. PubMed ID: 29321183
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients.
Moatter T; Aban M; Iqbal W; Pervez S
Pathol Oncol Res; 2015 Jan; 21(1):97-101. PubMed ID: 24789723
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study.
Piranda DN; Festa-Vasconcellos JS; Amaral LM; Bergmann A; Vianna-Jorge R
BMC Cancer; 2010 Nov; 10():613. PubMed ID: 21059239
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 (COX-2) polymorphism rs689466 may contribute to the increased susceptibility to post-traumatic osteomyelitis in Chinese population.
Wang L; Jiang N; Lin QR; Qin CH; Hu YJ; Yu B
Infect Dis (Lond); 2017; 49(11-12):817-823. PubMed ID: 28682162
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
7. Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.
Vieira-Monteiro Hde A; Freitas-Alves DR; Sobral-Leite M; Delou JM; Goulart-Citrangulo SM; do Nascimento CT; E Castro TN; Koifman S; Perini JA; Vianna-Jorge R
Cancer Biol Ther; 2016 Jun; 17(6):674-83. PubMed ID: 27195611
[TBL] [Abstract][Full Text] [Related]
8. Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
Markkula A; Simonsson M; Rosendahl AH; Gaber A; Ingvar C; Rose C; Jernström H
Int J Cancer; 2014 Oct; 135(8):1898-910. PubMed ID: 24599585
[TBL] [Abstract][Full Text] [Related]
9. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.
Li Q; Liu L; Liu Y; Zhou H; Yang Z; Yuan K; Min W
Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948
[TBL] [Abstract][Full Text] [Related]
10. Association of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects.
Dai ZJ; Shao YP; Ma XB; Xu D; Tang W; Kang HF; Lin S; Wang M; Ren HT; Wang XJ
Dis Markers; 2014; 2014():484729. PubMed ID: 25214704
[TBL] [Abstract][Full Text] [Related]
11. COX2 overexpression is a prognostic marker for Stage III breast cancer.
Kim HS; Moon HG; Han W; Yom CK; Kim WH; Kim JH; Noh DY
Breast Cancer Res Treat; 2012 Feb; 132(1):51-9. PubMed ID: 21533532
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in cyclooxygenase-2 gene and risk of developing coal workers' pneumoconiosis: a case-control study.
Bian LQ; Mao L; Shi J; Bi Y
Am J Ind Med; 2014 Aug; 57(8):866-71. PubMed ID: 24899082
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
14. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort.
Klintman M; Rosendahl AH; Randeris B; Eriksson M; Czene K; Hall P; Borgquist S
Breast Cancer Res Treat; 2022 Nov; 196(1):185-196. PubMed ID: 36040641
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.
Lee CH; Pao JB; Lu TL; Lee HZ; Lee YC; Liu CC; Huang CY; Lin VC; Yu CC; Yin HL; Huang SP; Bao BY
Int J Med Sci; 2016; 13(9):696-700. PubMed ID: 27647999
[TBL] [Abstract][Full Text] [Related]
17. Association of interleukin-10 gene variation with breast cancer prognosis.
Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
[TBL] [Abstract][Full Text] [Related]
18. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
19. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Langsenlehner U; Yazdani-Biuki B; Eder T; Renner W; Wascher TC; Paulweber B; Weitzer W; Samonigg H; Krippl P
Clin Cancer Res; 2006 Feb; 12(4):1392-4. PubMed ID: 16489098
[TBL] [Abstract][Full Text] [Related]
20. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
Elebro K; Borgquist S; Rosendahl AH; Markkula A; Simonsson M; Jirström K; Rose C; Ingvar C; Jernström H
Clin Cancer Res; 2017 Feb; 23(3):766-777. PubMed ID: 27810901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
